|By PR Newswire||
|August 19, 2014 04:55 PM EDT||
BIRMINGHAM, Ala., Aug. 19, 2014 /PRNewswire/ -- The Alabama Supreme Court, in a 6-3 decision on August 15, 2014, re-affirmed that patients can sue drug makers who mislead doctors into believing that prescription medicines the companies market do not cause harmful side‑effects. The case is Weeks v. Wyeth, and the decision came after the Supreme Court ruled against the drug makers in that same case last year. Heninger Garrison Davis attorneys Lew Garrison and Chris Hood represent the patient in the case, Danny Weeks.
The decision won a clear majority of the Alabama Supreme Court. Six of the nine justices voted for it. Associate Justice Michael F. Bolin authored the decision, joined by Associate Justices Stuart, Main, Wise, and Bryan, and including Associate Justice Shaw, who fully concurred and specially wrote to address responses to the earlier decision in the case.
Weeks' attorney Lew Garrison stated, "We agree with the decision, and we're very pleased that Danny and his wife Vicki will get their day in court. It's a victory for patients." Mr. Weeks was hurt by the brand makers of the drug Reglan, according to the suit.
The decision allows patients injured by prescription drugs to sue when their doctors are deceived, including when a pharmacist fills the prescription with a generic replica of the prescribed drug. Mr. Weeks received a generic replica of Reglan, as allowed by law. The law allowing the substitution, in Alabama and in all other states, requires the federal Food and Drug Administration to first approve the generic tablet as a bioequivalent replacement for the brand name drug. The substitution ensures that the patient receives the same medicine, not a different medicine. The makers of the branded drug furnish the information about it and are responsible by law for the information, including updating it to warn of significant risks to patients. The U.S. Supreme Court clearly confirmed that responsibility of branded drug companies in PLIVA v. Mensing, a landmark decision in 2011.
The facts of generic substitution for branded drugs are foreseeable and well known by everyone who works with prescription medicines -- doctors, pharmacists, and the brand defendants in the Weeks case. The brand defendants made Reglan and, according to the lawsuit, created the information about it which misled Danny Week's doctor, leading to the severe injury.
Weeks suffered a permanent and disabling neurological injury. He alleges that doctors who prescribed the brand drug were misled about the side-effects, and the deceit hurt him.
National media have covered the case. The Wall Street Journal, in reporting the first decision in it last year, explained the allegation that Weeks' doctor "relied on the representations made by the name brand manufacturer to assess the risks [of the drug]." The WSJ reported that "[a] brand name manufacturer could 'reasonably foresee' that a physician would rely on its warning label 'even if the patient ultimately consumed the generic version of the drug,' Justice Bolin wrote."
This victory for patients also is positive for doctors, who are owed a duty of truth by companies which promote the drugs the doctors prescribe. "Telling the truth about these drugs allows doctors to make good choices about which medicines to prescribe," according to Weeks' other attorney, Chris Hood. "When the truth is concealed, patients are hurt, which happened here."
The decision for Weeks is not an outlier, contrary to the view of some commentators. It rests on settled Alabama law, and other courts have ruled the same way, including the federal court which certified the question to the Alabama Supreme Court. Three other federal courts applying the laws of other states likewise have ruled against branded drug companies in favor of patients hurt by generic substitute drugs. Three state appeals courts have addressed the same question, and two of them -- in California and now in Alabama -- sided with the patients against makers of the brand drug. Alabama thus joins a number of other state and federal courts which permit this type of suit.
The similar federal decisions are recent. They are Colas v. Abbvie, Inc., 2014 WL 2699756 at *3 (N.D. Ill. June 13, 2014) (ruling under Virginia law for a patient who, like Danny Weeks, was dispensed a generic substitute drug and sued a brand defendant for fraud); Dolin v. SmithKline Beecham Corp., 2014 WL 804458 (N.D. Ill. Feb. 28, 2014) (ruling under Illinois law for a generic‑ingesting patient against brand defendant), mandamus denied, In re GlaxoSmithKline, LLC, 2014 WL 2506461 (7th Cir. June 4, 2014); Kellogg v. Wyeth, 762 F. Supp. 2d 694, 700 (D. Vt. 2010) (ruling under Vermont law for a generic‑ingesting patient against brand defendant).
The California decision in favor of patients is Conte v. Wyeth, Inc., 168 Cal. App. 4th 89, 85 Cal. Rptr. 3d 299 (2008) (ruling for a generic-ingesting patient under California law). The other state appellate decision on the question is Huck v. Wyeth, Inc., 2014 WL 3377071 (Iowa July 11, 2014), which was decided for the branded drug companies. Huck is a plurality decision, not a majority opinion, so it is not precedent even for Iowa courts, according to the Iowa Supreme Court. Audubon‑Exira Ready Mix, Inc. v. Illinois Cent. Gulf R. Co., 335 N.W.2d 148, 151 (Iowa 1983) (plurality decisions are not precedent).
W. Lewis Garrison, Jr., is a senior partner of Heninger Garrison Davis, LLC, headquartered in Birmingham, Alabama, and Christopher B. Hood is an associate attorney of HGD. They represent Danny and Vicki Weeks. HGD has offices in Atlanta, Birmingham, Los Angeles, New Jersey, New York, and metropolitan Washington, D.C. Our attorneys are leaders in national cases involving prescription drugs and medical devices.
Heninger Garrison Davis
2224 1st Avenue North
Birmingham, Alabama 35203
SOURCE Heninger Garrison Davis, LLC
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
Apr. 25, 2017 06:15 AM EDT Reads: 749
In his session at 20th Cloud Expo, Scott Davis, CTO of Embotics, will discuss how automation can provide the dynamic management required to cost-effectively deliver microservices and container solutions at scale. He will discuss how flexible automation is the key to effectively bridging and seamlessly coordinating both IT and developer needs for component orchestration across disparate clouds – an increasingly important requirement at today’s multi-cloud enterprise.
Apr. 25, 2017 06:00 AM EDT Reads: 4,260
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Apr. 25, 2017 05:00 AM EDT Reads: 792
Developers want to create better apps faster. Static clouds are giving way to scalable systems, with dynamic resource allocation and application monitoring. You won't hear that chant from users on any picket line, but helping developers to create better apps faster is the mission of Lee Atchison, principal cloud architect and advocate at New Relic Inc., based in San Francisco. His singular job is to understand and drive the industry in the areas of cloud architecture, microservices, scalability ...
Apr. 25, 2017 05:00 AM EDT Reads: 3,345
SYS-CON Events announced today that CollabNet, a global leader in enterprise software development, release automation and DevOps solutions, will be a Bronze Sponsor of SYS-CON's 20th International Cloud Expo®, taking place from June 6-8, 2017, at the Javits Center in New York City, NY. CollabNet offers a broad range of solutions with the mission of helping modern organizations deliver quality software at speed. The company’s latest innovation, the DevOps Lifecycle Manager (DLM), supports Value S...
Apr. 25, 2017 05:00 AM EDT Reads: 137
Join IBM November 2 at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA, and learn how to go beyond multi-speed it to bring agility to traditional enterprise applications. Technology innovation is the driving force behind modern business and enterprises must respond by increasing the speed and efficiency of software delivery. The challenge is that existing enterprise applications are expensive to develop and difficult to modernize. This often results in what Gartner calls ...
Apr. 25, 2017 04:30 AM EDT Reads: 2,984
SYS-CON Events announced today that Super Micro Computer, Inc., a global leader in compute, storage and networking technologies, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Supermicro (NASDAQ: SMCI), the leading innovator in high-performance, high-efficiency server technology, is a premier provider of advanced server Building Block Solutions® for Data Center, Cloud Computing, Enterprise IT, Hadoop/...
Apr. 25, 2017 04:30 AM EDT Reads: 1,982
Amazon has gradually rolled out parts of its IoT offerings in the last year, but these are just the tip of the iceberg. In addition to optimizing their back-end AWS offerings, Amazon is laying the ground work to be a major force in IoT – especially in the connected home and office. Amazon is extending its reach by building on its dominant Cloud IoT platform, its Dash Button strategy, recently announced Replenishment Services, the Echo/Alexa voice recognition control platform, the 6-7 strategic...
Apr. 25, 2017 04:15 AM EDT Reads: 4,990
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Apr. 25, 2017 04:15 AM EDT Reads: 157
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists will examine how DevOps helps to meet th...
Apr. 25, 2017 03:45 AM EDT Reads: 944
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Analytic. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
Apr. 25, 2017 03:45 AM EDT Reads: 796
With billions of sensors deployed worldwide, the amount of machine-generated data will soon exceed what our networks can handle. But consumers and businesses will expect seamless experiences and real-time responsiveness. What does this mean for IoT devices and the infrastructure that supports them? More of the data will need to be handled at - or closer to - the devices themselves.
Apr. 25, 2017 03:45 AM EDT Reads: 180
Building a cross-cloud operational model can be a daunting task. Per-cloud silos are not the answer, but neither is a fully generic abstraction plane that strips out capabilities unique to a particular provider. In his session at 20th Cloud Expo, Chris Wolf, VP & Chief Technology Officer, Global Field & Industry at VMware, will discuss how successful organizations approach cloud operations and management, with insights into where operations should be centralized and when it’s best to decentraliz...
Apr. 25, 2017 03:30 AM EDT Reads: 175
Judith Hurwitz is president and CEO of Hurwitz & Associates, a Needham, Mass., research and consulting firm focused on emerging technology, including big data, cognitive computing and governance. She is co-author of the book Cognitive Computing and Big Data Analytics, published in 2015. Her Cloud Expo session, "What Is the Business Imperative for Cognitive Computing?" is scheduled for Wednesday, June 8, at 8:40 a.m. In it, she puts cognitive computing into perspective with its value to the busin...
Apr. 25, 2017 03:30 AM EDT Reads: 3,560
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
Apr. 25, 2017 03:15 AM EDT Reads: 510